King Pharmaceuticals KG General Liability — Year 3
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's general liability — year 3.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's general liability — year 3?
- King Pharmaceuticals (KG) reported general liability — year 3 of 13.1% in Q4 2025.
- What does general liability — year 3 mean?
- This metric represents the third year of development for general liability claims, providing a more mature view of the loss experience for a specific policy cohort. It is essential for validating the accuracy of earlier reserve estimates and identifying long-term trends in claim costs.